Yong Cang

1.6k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Yong Cang is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yong Cang has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Yong Cang's work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (10 papers) and Multiple Myeloma Research and Treatments (6 papers). Yong Cang is often cited by papers focused on Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (10 papers) and Multiple Myeloma Research and Treatments (6 papers). Yong Cang collaborates with scholars based in China, United States and Singapore. Yong Cang's co-authors include Stephen P. Goff, Zhaozhu Qiu, Sally A. Nicholas, Pengbo Zhou, Jianxuan Zhang, Gregory Prelich, Baojie Li, Jiye Liu, Victor V. Keasler and Joseph M. Hyser and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Yong Cang

33 papers receiving 1.1k citations

Hit Papers

Routes to molecular glue degrader discovery 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Cang China 20 810 214 164 137 116 33 1.1k
Michele Pallaoro Italy 10 1.2k 1.5× 319 1.5× 107 0.7× 44 0.3× 85 0.7× 12 1.5k
Takayuki Shiratsuchi Japan 17 591 0.7× 185 0.9× 60 0.4× 26 0.2× 37 0.3× 22 1.0k
Kaiwei Liang China 18 1.3k 1.6× 178 0.8× 58 0.4× 105 0.8× 15 0.1× 44 1.6k
Maria Kontogiannea Canada 13 853 1.1× 263 1.2× 244 1.5× 20 0.1× 33 0.3× 17 1.3k
Constantinos Chronis United States 18 1.6k 2.0× 88 0.4× 70 0.4× 106 0.8× 35 0.3× 27 1.9k
I‐Chu Tseng United States 13 256 0.3× 89 0.4× 35 0.2× 100 0.7× 81 0.7× 15 630
Osman N. Özeş United States 13 649 0.8× 269 1.3× 110 0.7× 33 0.2× 58 0.5× 31 1.1k
John Anagli United States 21 603 0.7× 72 0.3× 104 0.6× 56 0.4× 26 0.2× 31 1.0k
Gayathri Swaminathan United States 13 514 0.6× 237 1.1× 95 0.6× 54 0.4× 10 0.1× 21 898
Caroline Saucier Canada 21 751 0.9× 412 1.9× 80 0.5× 17 0.1× 235 2.0× 37 1.4k

Countries citing papers authored by Yong Cang

Since Specialization
Citations

This map shows the geographic impact of Yong Cang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Cang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Cang more than expected).

Fields of papers citing papers by Yong Cang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Cang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Cang. The network helps show where Yong Cang may publish in the future.

Co-authorship network of co-authors of Yong Cang

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Cang. A scholar is included among the top collaborators of Yong Cang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Cang. Yong Cang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zefan, Minfang Song, Hu L, et al.. (2025). Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity. Journal of Hepatology. 83(2). 397–410. 1 indexed citations
2.
Liu, Yanfen, Jieyun Bai, Dong Li, & Yong Cang. (2025). Routes to molecular glue degrader discovery. Trends in Biochemical Sciences. 50(2). 134–142. 16 indexed citations breakdown →
3.
Liu, Yanfen, et al.. (2023). Mini PROTACs: N-end rule-mediated degradation on the horizon. Trends in Biochemical Sciences. 49(1). 5–7. 7 indexed citations
4.
Zhu, Xiaotong, Haixia Liu, Li Chen, et al.. (2022). Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation. Cell chemical biology. 29(11). 1616–1629.e12. 21 indexed citations
5.
Chen, Junyi, Tianyu Song, Jae Hyung Jung, et al.. (2022). Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling. Cell chemical biology. 29(8). 1260–1272.e8. 12 indexed citations
6.
Song, Tianyu, Min Long, Haixin Zhao, et al.. (2021). Tumor evolution selectively inactivates the core microRNA machinery for immune evasion. Nature Communications. 12(1). 7003–7003. 13 indexed citations
7.
Du, Gang, et al.. (2019). Safe and effective subcutaneous adipolysis in minipigs by a collagenase derivative. PLoS ONE. 14(12). e0227202–e0227202. 4 indexed citations
8.
Liu, Jiye, Tianyu Song, Lijie Xing, et al.. (2018). A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity. Leukemia. 33(1). 171–180. 65 indexed citations
9.
Song, Tianyu, Jiye Liu, Tingyue Zhang, et al.. (2018). CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory. PLoS Genetics. 14(1). e1007165–e1007165. 26 indexed citations
10.
Song, Tianyu, et al.. (2017). Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase. Journal of Biological Chemistry. 292(9). 3683–3691. 6 indexed citations
11.
Li, Gaofeng, Tong Ji, Chen Jiang, et al.. (2017). CRL4DCAF8 Ubiquitin Ligase Targets Histone H3K79 and Promotes H3K9 Methylation in the Liver. Cell Reports. 18(6). 1499–1511. 24 indexed citations
12.
Chan, Barden, Michelle Clasquin, Gromoslaw A. Smolen, et al.. (2016). A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2. Human Molecular Genetics. 25(11). 2182–2193. 33 indexed citations
13.
Chen, Jiang, Tong Ji, Jie Zhao, et al.. (2016). Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint. Oncotarget. 7(27). 41274–41284. 39 indexed citations
14.
Liu, Jiye, Zhenghao Xu, Feng Yan, et al.. (2014). CRL4ACRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis. Nature Communications. 5(1). 3924–3924. 84 indexed citations
15.
Endo, Yoko, Mingjun Zhang, Sachie Yamaji, & Yong Cang. (2012). Genetic Abolishment of Hepatocyte Proliferation Activates Hepatic Stem Cells. PLoS ONE. 7(2). e31846–e31846. 18 indexed citations
16.
Hodgson, Amanda, Joseph M. Hyser, Victor V. Keasler, Yong Cang, & Betty L. Slagle. (2012). Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology. 426(1). 73–82. 74 indexed citations
17.
Qiu, Zhaozhu, Yong Cang, & Stephen P. Goff. (2010). Abl Family Tyrosine Kinases Are Essential for Basement Membrane Integrity and Cortical Lamination in the Cerebellum. Journal of Neuroscience. 30(43). 14430–14439. 38 indexed citations
18.
Zhuo, Xianyi, Yong Cang, Hui Yan, Jun Bu, & Baohua Shen. (2010). The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities. Accident Analysis & Prevention. 42(6). 2179–2184. 13 indexed citations
19.
Cang, Yong, Jianxuan Zhang, Sally A. Nicholas, et al.. (2006). Deletion of DDB1 in Mouse Brain and Lens Leads to p53-Dependent Elimination of Proliferating Cells. Cell. 127(5). 929–940. 127 indexed citations
20.
Cang, Yong. (1999). A new regulatory domain on the TATA-binding protein. The EMBO Journal. 18(23). 6662–6671. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026